Ticker Details
Embecta Corp.
IPO Date:	April 1, 2022
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$198.75M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 2.41%
Avg Daily Range (30 D):	$0.07 | 2.07%
Avg Daily Range (90 D):	$0.19 | 2.90%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	1.54M
Avg Daily Volume (90 D):	1.6M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	117
Avg Trade Size (Sh.) (90 D):	111

Institutional Trades
Total Institutional Trades:	1,598
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$1.8M
Avg Institutional Trade (90 D):	$1.47M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.33M
Avg Closing Trade (30 D):	$1.89M
Avg Closing Trade (90 D):	$1.55M
Avg Closing Volume:	137.83K

News

Jul 15, 2026 @ 10:32 PM Embecta Corp. (EMBC) Faces Securities Class Action... Source: Hagens Berman

Jul 14, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Embecta Co... Source: Bronstein, Gewirtz & Grossman Llc

Jul 13, 2026 @ 8:48 PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encoura... Source: Rosen Law Firm

Jul 13, 2026 @ 5:33 PM Deadline Alert: Embecta Corp. (EMBC) Shareholders ... Source: Glancy Prongay Wolke & Rotter Llp

Jul 11, 2026 @ 12:33 PM EMBC SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Remi... Source: Faruqi & Faruqi, Llp

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.07	$.75	$.46
Diluted EPS	$-.07	$.74	$.44
Revenue	$221.8M	$261.2M	$264M
Gross Profit	$127.8M	$161.7M	$158.5M
Net Income / Loss	$-4.1M	$44.1M	$26.4M
Operating Income / Loss	$35M	$83.3M	$56.5M
Cost of Revenue	$94M	$99.5M	$105.5M
Net Cash Flow	$-10.9M	$-24.9M	$-4.9M
PE Ratio